Rodrigo Arnedo-Daza

Bogota, DC, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine

The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine

Journal: Archivos de cardiologia de Mexico

Published: July 01, 2026

Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.

Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: December 12, 2025

Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique.

Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: January 23, 2025

S.E.N., SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification.

S.E.N., SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification.

Journal: Kidney international

Published: January 11, 2025

Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective.

Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective.

Journal: Jornal brasileiro de nefrologia

Published: June 02, 2024

Impact of HbA1c Reduction on Major Kidney Outcomes in Type 2 Diabetes With Poor Glycemic Control and Advanced CKD.

Impact of HbA1c Reduction on Major Kidney Outcomes in Type 2 Diabetes With Poor Glycemic Control and Advanced CKD.

Journal: International journal of endocrinology

Published: April 29, 2024

Prediabetes and CKD: Does a causal relationship exist.

Prediabetes and CKD: Does a causal relationship exist.

Journal: Nefrologia

Published: April 28, 2024

The Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA), Associated with Renal Compromise and Cutaneous Calcinosis: A Case Report and Literature Review.

The Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA), Associated with Renal Compromise and Cutaneous Calcinosis: A Case Report and Literature Review.

Journal: Case reports in nephrology

Published: January 25, 2024

The ASSESS-AKI study: urinary epidermal growth factor association with reduced risk of MAKE and age.

The ASSESS-AKI study: urinary epidermal growth factor association with reduced risk of MAKE and age.

Journal: Kidney international

Published: September 08, 2023

Novel Biomarkers of Diabetic Kidney Disease.

Novel Biomarkers of Diabetic Kidney Disease.

Journal: Biomolecules

Published: February 15, 2023

Insulin and the kidneys: a contemporary view on the molecular basis.

Insulin and the kidneys: a contemporary view on the molecular basis.

Journal: Frontiers in nephrology

Published: December 28, 2022

Critically Ill Patients with Renal Hyperfiltration: Optimizing Antibiotic Dose.

Critically Ill Patients with Renal Hyperfiltration: Optimizing Antibiotic Dose.

Journal: International journal of nephrology

Published: August 07, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026